Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline. 1998

Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan. ytotsuka@gan2.ncc.go.jp

Norharman (9H-pyrido[3,4-b]indole), widely distributed in our environment, including cigarette smoke and cooked foodstuffs, is not mutagenic to Salmonella strains, but becomes mutagenic to S.typhimurium TA98 and YG1024 with S9 mix in the presence of non-mutagenic aromatic amines such as aniline and o-toluidine. To elucidate the mechanisms of co-mutagenicity, we tried to isolate the mutagen(s) produced by a reaction between norharman and aniline with S9 mix. By HPLC purification, two mutagenic compounds (I and II), one (I) showing mutagenicity with and the other (II) without S9 mix, were isolated. The structure of compound I was deduced to be a coupled compound of norharman and aniline, 9-(4'-aminophenyl)-9H-pyrido[3,4-b]indole (aminophenylnorharman), by a variety of spectrometry techniques and this was confirmed by its chemical synthesis. The mutagenic activity of this novel heterocyclic amine was tested using the pre-incubation method and was found to induce 187,000 revertants in TA98 and 1,783,000 revertants in YG1024 per microg with S9 mix. Compound II was shown to be hydroxyaminophenylnorharman. Formation of the same DNA adducts was observed in YG1024 when aminophenylnorharman or a mixture of norharman plus aniline was incubated with S9 mix. The hydroxyamino derivative also yielded the same DNA adducts in YG1024. Thus, the appearance of mutagenicity by norharman with aniline in the presence of S9 mix suggests that the coupled mutagenic compound, aminophenylnorharman, is formed from norharman and aniline, then converted to the hydroxyamino derivative and forms DNA adducts to induce mutations in TA98 and YG1024.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002243 Carbolines A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles. Carboline,Pyrido(4,3-b)Indole,Beta-Carbolines,Pyrido(4,3-b)Indoles,Beta Carbolines
D006247 Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic PARKINSON DISEASE in the 1920's. 9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-,Banisterine,Leucoharmine,Telepathine,Yageine
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018736 DNA Adducts The products of chemical reactions that result in the addition of extraneous chemical groups to DNA. DNA Adduct,Adduct, DNA,Adducts, DNA

Related Publications

Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
October 2004, Carcinogenesis,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
September 2001, Toxicology and applied pharmacology,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
December 2003, Carcinogenesis,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
March 2002, Human & experimental toxicology,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
September 2002, Mutation research,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
October 2002, Chemical research in toxicology,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
February 2001, Cancer letters,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
July 1996, Carcinogenesis,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
January 1981, Mutation research,
Y Totsuka, and N Hada, and K Matsumoto, and N Kawahara, and Y Murakami, and Y Yokoyama, and T Sugimura, and K Wakabayashi
July 2001, Mutation research,
Copied contents to your clipboard!